Reiman, Eric M <br/><br/>
Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease.  [electronic resource] 

 -  Proceedings of the National Academy of Sciences of the United States of America  Apr 2009 
 - 6820-5 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1091-6490 
<br/><br/><label>Standard No.: </label>10.1073/pnas.0900345106  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Alzheimer Disease--genetics<br/>Amyloid beta-Peptides--metabolism<br/>Apolipoprotein E4--genetics<br/>Brain Mapping<br/>Cognition<br/>Gene Dosage<br/>Genetic Predisposition to Disease<br/>Heterozygote<br/>Homozygote<br/>Humans<br/>Magnetic Resonance Imaging<br/>Middle Aged<br/>Neuropsychological Tests